These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 8625339)
1. Capsules and suppositories of methadone for patients on high-dose opioids for cancer pain: clinical and economic considerations. Watanabe S; Belzile M; Kuehn N; Hanson J; Bruera E Cancer Treat Rev; 1996 Jan; 22 Suppl A():131-6. PubMed ID: 8625339 [TBL] [Abstract][Full Text] [Related]
2. Custom-made capsules and suppositories of methadone for patients on high-dose opioids for cancer pain. Bruera E; Watanabe S; Fainsinger RL; Spachynski K; Suarez-Almazor M; Inturrisi C Pain; 1995 Aug; 62(2):141-146. PubMed ID: 8545138 [TBL] [Abstract][Full Text] [Related]
3. Rotation to methadone after opioid dose escalation: How should individualization of dosing occur? Zimmermann C; Seccareccia D; Booth CM; Cottrell W J Pain Palliat Care Pharmacother; 2005; 19(2):25-31. PubMed ID: 16061458 [TBL] [Abstract][Full Text] [Related]
4. Switching from methadone to a different opioid: what is the equianalgesic dose ratio? Walker PW; Palla S; Pei BL; Kaur G; Zhang K; Hanohano J; Munsell M; Bruera E J Palliat Med; 2008 Oct; 11(8):1103-8. PubMed ID: 18980450 [TBL] [Abstract][Full Text] [Related]
5. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626 [TBL] [Abstract][Full Text] [Related]
6. Intravenous methadone in the management of chronic cancer pain: safe and effective starting doses when substituting methadone for fentanyl. Santiago-Palma J; Khojainova N; Kornick C; Fischberg DJ; Primavera LH; Payne R; Manfredi P Cancer; 2001 Oct; 92(7):1919-25. PubMed ID: 11745266 [TBL] [Abstract][Full Text] [Related]
7. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain. Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307 [TBL] [Abstract][Full Text] [Related]
9. Fentanyl by continuous subcutaneous infusion for the management of cancer pain: a retrospective study. Watanabe S; Pereira J; Hanson J; Bruera E J Pain Symptom Manage; 1998 Nov; 16(5):323-6. PubMed ID: 9846027 [TBL] [Abstract][Full Text] [Related]
10. Dose ratio between morphine and methadone in patients with cancer pain: a retrospective study. Lawlor PG; Turner KS; Hanson J; Bruera ED Cancer; 1998 Mar; 82(6):1167-73. PubMed ID: 9506365 [TBL] [Abstract][Full Text] [Related]
11. Opioid Rotation to Methadone for Refractory Cancer Pain: A Case Series. Khoo SY; Aziz FA; Nambbiar P J Pain Palliat Care Pharmacother; 2019; 33(3-4):125-130. PubMed ID: 31638444 [TBL] [Abstract][Full Text] [Related]
12. Methadone rotation for cancer patients with refractory pain in a palliative care unit: an observational study. Rhondali W; Tremellat F; Ledoux M; Ciais JF; Bruera E; Filbet M J Palliat Med; 2013 Nov; 16(11):1382-7. PubMed ID: 24116946 [TBL] [Abstract][Full Text] [Related]
13. Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine. Bruera E; Pereira J; Watanabe S; Belzile M; Kuehn N; Hanson J Cancer; 1996 Aug; 78(4):852-7. PubMed ID: 8756381 [TBL] [Abstract][Full Text] [Related]
14. Opioid plasma concentrations during a switch from transdermal fentanyl to methadone. Mercadante S; Villari P; Ferrera P; Casuccio A; Gambaro V J Palliat Med; 2007 Apr; 10(2):338-44. PubMed ID: 17472504 [TBL] [Abstract][Full Text] [Related]
15. Low-dose methadone has an analgesic effect in neuropathic pain: a double-blind randomized controlled crossover trial. Morley JS; Bridson J; Nash TP; Miles JB; White S; Makin MK Palliat Med; 2003 Oct; 17(7):576-87. PubMed ID: 14594148 [TBL] [Abstract][Full Text] [Related]
16. Improved Pain Control in Terminally Ill Cancer Patients by Introducing Low-Dose Oral Methadone in Addition to Ongoing Opioid Treatment. Fürst P; Lundström S; Klepstad P; Runesdotter S; Strang P J Palliat Med; 2018 Feb; 21(2):177-181. PubMed ID: 28792784 [TBL] [Abstract][Full Text] [Related]
17. Morphine-methadone opioid rotation in cancer patients: analysis of dose ratio predicting factors. Benítez-Rosario MA; Salinas-Martín A; Aguirre-Jaime A; Pérez-Méndez L; Feria M J Pain Symptom Manage; 2009 Jun; 37(6):1061-8. PubMed ID: 19171458 [TBL] [Abstract][Full Text] [Related]
18. Intravenous methadone for cancer pain unrelieved by morphine and hydromorphone: clinical observations. Manfredi PL; Borsook D; Chandler SW; Payne R Pain; 1997 Mar; 70(1):99-101. PubMed ID: 9106815 [TBL] [Abstract][Full Text] [Related]
19. Switching methadone: a 10-year experience of 345 patients in an acute palliative care unit. Mercadante S Pain Med; 2012 Mar; 13(3):399-404. PubMed ID: 22360828 [TBL] [Abstract][Full Text] [Related]
20. [Treating hospitalized children in severe pain with oral methadone]. Shir Y; Shvelzon V; Rosen G Harefuah; 1998 Mar; 134(6):438-41, 503. PubMed ID: 10909571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]